Phibro Animal Health Corp (NASDAQ:PAHC) has earned an average recommendation of “Hold” from the eight brokerages that are presently covering the firm. Two analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $29.17.

PAHC has been the subject of a number of analyst reports. Piper Jaffray Companies lifted their target price on shares of Phibro Animal Health Corp from $32.00 to $34.00 and gave the stock an “overweight” rating in a report on Wednesday, February 8th. Zacks Investment Research raised shares of Phibro Animal Health Corp from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a report on Thursday, May 11th.

COPYRIGHT VIOLATION WARNING: “Phibro Animal Health Corp (PAHC) Receives Consensus Recommendation of “Hold” from Analysts” was first published by American Banking News and is owned by of American Banking News. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/05/19/phibro-animal-health-corp-pahc-receives-consensus-recommendation-of-hold-from-analysts.html.

Shares of Phibro Animal Health Corp (NASDAQ:PAHC) traded down 0.73% during midday trading on Friday, hitting $34.10. The stock had a trading volume of 98,851 shares. The stock has a market cap of $1.35 billion, a PE ratio of 21.18 and a beta of 1.34. Phibro Animal Health Corp has a 52 week low of $17.96 and a 52 week high of $35.15. The stock has a 50-day moving average of $29.85 and a 200 day moving average of $28.55.

Phibro Animal Health Corp (NASDAQ:PAHC) last released its earnings results on Monday, May 8th. The company reported $0.37 EPS for the quarter, hitting analysts’ consensus estimates of $0.37. Phibro Animal Health Corp had a net margin of 7.90% and a return on equity of 63.70%. The firm had revenue of $190 million during the quarter, compared to analyst estimates of $185.90 million. During the same quarter in the previous year, the business earned $0.38 EPS. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. Analysts anticipate that Phibro Animal Health Corp will post $1.45 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 22nd. Investors of record on Wednesday, May 31st will be given a $0.10 dividend. The ex-dividend date of this dividend is Friday, May 26th. This represents a $0.40 annualized dividend and a yield of 1.16%. Phibro Animal Health Corp’s dividend payout ratio is currently 26.85%.

In related news, Director Gerald K. Carlson sold 12,000 shares of the business’s stock in a transaction on Monday, March 20th. The shares were sold at an average price of $28.13, for a total value of $337,560.00. Following the sale, the director now directly owns 12,000 shares of the company’s stock, valued at approximately $337,560. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gerald K. Carlson sold 63,338 shares of the business’s stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $33.31, for a total transaction of $2,109,788.78. Following the completion of the sale, the director now directly owns 50 shares in the company, valued at $1,665.50. The disclosure for this sale can be found here. Insiders sold a total of 235,296 shares of company stock worth $7,505,834 over the last ninety days. 48.09% of the stock is currently owned by insiders.

Large investors have recently bought and sold shares of the stock. New York State Teachers Retirement System boosted its stake in Phibro Animal Health Corp by 1.4% in the fourth quarter. New York State Teachers Retirement System now owns 7,343 shares of the company’s stock valued at $215,000 after buying an additional 100 shares in the last quarter. Renaissance Technologies LLC bought a new stake in Phibro Animal Health Corp during the fourth quarter valued at approximately $407,000. Allianz Asset Management AG boosted its stake in Phibro Animal Health Corp by 9.8% in the fourth quarter. Allianz Asset Management AG now owns 29,585 shares of the company’s stock valued at $867,000 after buying an additional 2,630 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Phibro Animal Health Corp during the fourth quarter valued at approximately $226,000. Finally, Trexquant Investment LP bought a new stake in Phibro Animal Health Corp during the fourth quarter valued at approximately $765,000. 47.35% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Corp Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

5 Day Chart for NASDAQ:PAHC

Receive News & Ratings for Phibro Animal Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.